ICD-10-PCS Billable Code

07584ZZ

Destruction Lymphatic, Internal Mammary, Right to No Qualifier with No Device, Percutaneous Endoscopic Approach

Procedural Specifications

Clinical Axis Detail Definition
Section0 Medical and Surgical
Body System7 Lymphatic and Hemic Systems
Operation5 Destruction
Body Part8 Lymphatic, Internal Mammary, Right
Approach4 Percutaneous Endoscopic
DeviceZ No Device
QualifierZ No Qualifier

Operation Definition

Physical eradication of all or a portion of a body part by the direct use of energy, force, or a destructive agent

Procedure Overview

Destruction procedures in the lymphatic and hemic systems eliminate abnormal tissue in place, using heat, cold, chemicals, or other energy sources rather than physically cutting it out. In practice this most often means sclerotherapy or ablation of lymphatic malformations, cystic hygromas, or enlarged lymph nodes, where injecting or applying an agent causes the abnormal tissue to shrink and scar down.

This approach is favored when surgical removal would be difficult or risky, such as malformations located near major blood vessels or nerves, or in children where minimizing surgical trauma matters. It can also be used to manage lymphoceles that have not responded to simple drainage.

Because the tissue is destroyed rather than removed, there is nothing sent to pathology, which is a key practical difference from excisional approaches.

Anatomy & Axis Detail

Lymphatic, Internal Mammary, Right

The right internal mammary lymph nodes lie along the internal mammary vessels just beneath the sternum and serve as an alternate drainage pathway for the breast, particularly relevant when medially located right breast tumors are being staged or treated. Destruction of this nodal tissue means it is eradicated in place, often via a thermal or energy-based ablative technique reached through a limited parasternal or minimally invasive approach, without physically excising the nodes. Because these nodes are less routinely sampled than axillary nodes and sit close to the internal mammary vessels and pleura, documentation specifying the right internal mammary location and the destructive, in-situ approach is important for accurate coding.

Approach: Percutaneous Endoscopic

Percutaneous Endoscopic combines a puncture through skin or mucous membrane with insertion of an endoscope to visualize the procedure internally, as in laparoscopic cholecystectomy. It is distinguished from plain Percutaneous by the presence of scope-guided visualization, and from Via Natural or Artificial Opening Endoscopic by its route being a new puncture rather than an existing orifice or stoma.

Coding & Documentation

Coders should assign Destruction when the documentation describes obliterating tissue in place, through sclerosing agents, laser, radiofrequency, or similar means, with no specimen extracted from the body. The specific agent or energy source used should be reflected in the approach and, where applicable, the qualifier.

A common error is coding a sclerotherapy injection as Introduction of a substance rather than Destruction of the target tissue, since both involve injecting an agent but only one is aimed at eradicating the lymphatic structure itself. Reviewing physician intent and the described tissue effect, rather than just the act of injection, resolves this distinction.

Commonly Confused With

ExcisionDestruction is often confused with Excision, since both can address an abnormal lymphatic mass; the deciding factor is whether tissue is physically removed and sent to pathology (Excision) versus eradicated in place with no specimen (Destruction).
IntroductionIt also overlaps with Introduction when a substance is instilled, differentiated by whether the goal is chemical delivery or tissue eradication.